GlassScriptPhysician profile
Don Nelson Tait
NPI 1902344237
$15,456.94
in general payments reported to CMS, 2019-2025
33 companies · $1,004 in 2025
The $1,004 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.95 · 2020: $633 · 2021: $2,036 · 2022: $2,191 · 2023: $4,630 · 2024: $4,897 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,911 · Travel and Lodging: $2,301 · Grant: $1,126 · Education: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,911.26 |
| Travel and Lodging | $2,301.16 |
| Grant | $1,126.44 |
| Education | $192.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,238.41 | 2020-2025 | Optis, Xience Skypoint, Aveir |
| Boston Scientific Corporation | $2,376.39 | 2019-2024 | Watchman Access System, Ranger, Ekosonic |
| Edwards Lifesciences Corporation | $1,497.29 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $1,073.15 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $640.46 | 2020-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $607.45 | 2023-2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $550.54 | 2021-2025 | Camzyos |
| Shockwave Medical, INC | $518.28 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $462.68 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $330.10 | 2022-2025 | Lutonix Drug Coated Balloon, Crosser Iq, Crosser Iq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.93 | 2021-2025 | Jardiance |
| Abiomed | $228.75 | 2024-2025 | Impella |
| Astellas Pharma US INC | $187.98 | 2021 | |
| Philips North America LLC | $184.45 | 2021-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $160.75 | 2023-2025 | Lifevest |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $142.57 | 2024 | Penumbra System |
| Angiodynamics, INC. | $141.24 | 2023 | Alphavac |
| Impulse Dynamics (USA) INC. | $122.20 | 2024 | Optimizer |
| Chiesi USA, INC. | $121.18 | 2024 | Kengreal, Cleviprex |
| Cvrx, INC. | $115.54 | 2025 | Barostim Neo System |
| Medtronic, INC. | $75.22 | 2022-2025 | Symplicity G3 |
| Cardiva Medical, INC. | $72.86 | 2023-2024 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Cordis US Corp. | $66.98 | 2023 | Mynxgrip, Rain Sheath Transradial, Zephyr |
| Novartis Pharmaceuticals Corporation | $54.93 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $44.72 | 2020-2025 | Wainua, Farxiga |
| Heartflow, INC. | $37.87 | 2025 | |
| Janssen Pharmaceuticals, INC | $30.88 | 2023-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $27.66 | 2025 | Verquvo |
| Kiniksa Pharmaceuticals, LTD. | $24.41 | 2023 | Arcalyst |
| Daiichi Sankyo INC. | $18.59 | 2023 | Injectafer |
| Stryker Corporation | $18.06 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $14.23 | 2021 | |
| Terumo Medical Corporation | $14.19 | 2023 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Tait listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.